Clinical trials: Schizophenia Disorder
Schizophenia Disorder
A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia.
A phase II, proof-of-concept, national, multicenter, randomized, double-blind clinical trial to compare the efficacy and safety of WAS123 in the maintenance treatment of patients with schizophrenia, with a parallel design between…
- Trial name
- REORDER (NCT07843056)
- Testing
- WAS123, Aripiprazole (Fixed dose)
- Where
- Brazil
- Volunteers
- 121 people
- Sponsor
- EMS